Verena E. Deutschmeyer, Nico A. Schlaudraff, Sara K. Walesch, Janine Moyer, Anna M. Sokol, Johannes Graumann, Wolfgang Meissner, Marc Schneider, Thomas Muley, Peter Helmbold, Markus Schwinn, Antje M. Richter, M. Lienhard Schmitz, Reinhard H. Dammann
{"title":"SIAH3 is frequently epigenetically silenced in cancer and regulates mitochondrial metabolism","authors":"Verena E. Deutschmeyer, Nico A. Schlaudraff, Sara K. Walesch, Janine Moyer, Anna M. Sokol, Johannes Graumann, Wolfgang Meissner, Marc Schneider, Thomas Muley, Peter Helmbold, Markus Schwinn, Antje M. Richter, M. Lienhard Schmitz, Reinhard H. Dammann","doi":"10.1002/ijc.35202","DOIUrl":null,"url":null,"abstract":"<p>Of the <i>seven</i> in absentia <i>homologue</i> (SIAH) family, three members have been identified in the human genome. In contrast to the E3 ubiquitin ligase encoding <i>SIAH1</i> and <i>SIAH2</i>, little is known on the regulation and function of <i>SIAH3</i> in tumorigenesis. In this study, we reveal that <i>SIAH3</i> is frequently epigenetically silenced in different cancer entities, including cutaneous melanoma, lung adenocarcinoma and head and neck cancer. Low <i>SIAH3</i> levels correlate with an impaired survival of cancer patients. Additionally, induced expression of <i>SIAH3</i> reduces cell proliferation and induces cell death. Functionally, SIAH3 negatively affects cellular metabolism by shifting cells form aerobic oxidative phosphorylation to glycolysis. SIAH3 is localized in the mitochondrion and interacts with proteins involved in mitochondrial ribosome biogenesis and translation. We also report that SIAH3 interacts with ubiquitin ligases, including SIAH1 or SIAH2, and is degraded by them. These results suggest that SIAH3 acts as an epigenetically controlled tumor suppressor by regulating cellular metabolism through the inhibition of oxidative phosphorylation.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"156 2","pages":"353-367"},"PeriodicalIF":5.7000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.35202","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35202","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Of the seven in absentia homologue (SIAH) family, three members have been identified in the human genome. In contrast to the E3 ubiquitin ligase encoding SIAH1 and SIAH2, little is known on the regulation and function of SIAH3 in tumorigenesis. In this study, we reveal that SIAH3 is frequently epigenetically silenced in different cancer entities, including cutaneous melanoma, lung adenocarcinoma and head and neck cancer. Low SIAH3 levels correlate with an impaired survival of cancer patients. Additionally, induced expression of SIAH3 reduces cell proliferation and induces cell death. Functionally, SIAH3 negatively affects cellular metabolism by shifting cells form aerobic oxidative phosphorylation to glycolysis. SIAH3 is localized in the mitochondrion and interacts with proteins involved in mitochondrial ribosome biogenesis and translation. We also report that SIAH3 interacts with ubiquitin ligases, including SIAH1 or SIAH2, and is degraded by them. These results suggest that SIAH3 acts as an epigenetically controlled tumor suppressor by regulating cellular metabolism through the inhibition of oxidative phosphorylation.
期刊介绍:
The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:
-Cancer Epidemiology-
Cancer Genetics and Epigenetics-
Infectious Causes of Cancer-
Innovative Tools and Methods-
Molecular Cancer Biology-
Tumor Immunology and Microenvironment-
Tumor Markers and Signatures-
Cancer Therapy and Prevention